When Donald Trump promised to take on entrenched special interests in Washington, he wasn’t just talking about bureaucrats and lobbyists. He meant business—and that includes standing up to one of the most powerful industries in America: Big Pharma.
Despite a coordinated pressure campaign, Trump’s administration continues to support the federal 340B Drug Pricing Program, a critical tool for hospitals that serve low-income and rural communities.
What Is the 340B Program—and Why Does It Matter?
Enacted in 1992, the 340B program requires pharmaceutical companies to provide discounted medications to qualifying hospitals and clinics. It’s not funded by taxpayers—drugmakers foot the bill. And for many rural hospitals across the country, those discounts are the difference between staying open or closing their doors.
Without the 340B program, smaller…
